Compliance & EnforcementCompliance & Enforcement
ArchiveCompliance & Enforcement
14,067 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Supreme Court Passes on Bid to Revive JPMorgan Fraud Claims
COVID-19: Important Changes to Employment Law
Navigating the Coronavirus Crisis for Compliance Professionals: Part 1 – Getting Started
Evidence Too Thin to Show Pharma’s Speaker Events Were Actually Kickbacks; United States District Court for the Southern District of New York No. 13-CV-3700 (KMW), U.S. ex rel. Steven M. Camburn v. Novartis Pharmaceuticals Corporation
Ground Breaking Decision in Federal Appeals Court Protects Whistleblowers and Civil Rights Plaintiffs from Excessive Court Costs
Unprecedented Discovery Orders Vacated: Fourth Circuit Confirms Government Contractors Do Not Waive Privilege by Disclosing Facts Uncovered During an Internal Investigation Under the FAR’s Mandatory Disclosure Rule
The Special Inspector General for Pandemic Recovery – Crisis Funding Comes with Heightened Investigation Risk
Board Governance Challenges in COVID-19 Crisis
Federal Antitrust Agencies Encourage Appropriate Competitor Collaboration to Address the COVID-19 Crisis
Defendant Says He Can’t Be Held Vicariously Responsible for Misconduct, But Government Says It’s Personal; United States District Court for the Middle District of Tennessee, Nashville Division No. 3:16-cv-0549, U.S. and the State of Tennessee ex rel. Suzanne Alt et al. v. Anesthesia Services Associates PLLC d/b/a Comprehensive Pain Specialists, et al.
Government Cannot Use Relator’s Qui Tam Case to Argue He Also Engaged in the Alleged Fraud; United States District Court for the Middle District of Tennessee, Nashville Division No. 3:16-cv-0549, U.S. and the State of Tennessee ex rel. Suzanne Alt et al. v. Anesthesia Services Associates PLLC d/b/a Comprehensive Pain Specialists, et al.
Defense Production Act, Rated Orders & the FCA: Long-Term Liability Amid a Current Crisis?
DOJ Urged to Create Coronavirus False Claims Task Force
The CARES Act and Risk of FCA Exposure
DOJ Investigating COVID-19 Fraud
Federal Authorities Crack Down on Fraudulent COVID-19 Schemes
DOJ Downplays Circuit Split on FCA Deference to Government Dismissals of Whistleblower Actions
New Paper Highlights Need for Changes in False Claims Act
Pentagon Investigator Appointed to Guard Against Abuse of Coronavirus Money
Keep reading
